Rafael Holdings Inc Asset Turnover Ratio (RFL), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Rafael Holdings Inc  (NYSE: RFL)
 

Rafael Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Rafael Holdings Inc's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the third quarter (Apr 30 2026)

Within sector 168 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the III Quarter 2026, to 3364, from total ranking in the at 3495.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RFL Asset Turnover Ratio (Apr 30 2026)
III. Quarter		 (Jan 31 2026)
2026		 (Oct 31 2025)
I. Quarter		 (Jul 31 2025)
IV. Quarter		 (Apr 30 2025)
III. Quarter
Y / Y Asset Change -14.21 % 80.1 % 18.86 % 44.07 % 6.37 %
Y / Y Revenue Change -50.55 % 174.03 % 87.5 % 112.12 % 7.74 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
RFL's Total Ranking # 3364 # 3495 # 3273 # 3478 # 3344
Seq. Asset Change -7.32 % -5.49 % -7.22 % 5.56 % 94.56 %
Seq. Revenue Change -15.17 % -12.08 % -31.43 % -3.31 % 370.13 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 169
Healthcare Sector # 516
Overall Market # 3364

Asset Turnover Ratio Statistics
High Average Low
18.63 5.67 0.22
(Jan 31 2021)   (Jan 31 2024)




RFL Company Profile • Back to RFL Efficiency Comparisons • Compare RFL Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2026 Assets at quarter ending Apr 30 2026
Tao Synergies Inc   0.03 $ 0.688  Millions$ 23.758  Millions
Dbv Technologies S a   0.03 $ 5.783  Millions$ 209.755  Millions
Northwest Biotherapeutics Inc  0.03 $ 1.497  Millions$ 55.374  Millions
Onkure Therapeutics Inc   0.03 $ 2.816  Millions$ 104.929  Millions
Atrium Therapeutics Inc   0.03 $ 36.817  Millions$ 1,438.386  Millions
Eyepoint Inc   0.03 $ 7.614  Millions$ 301.264  Millions
Mangoceuticals Inc   0.02 $ 0.415  Millions$ 16.978  Millions
Uniqure N v   0.02 $ 18.093  Millions$ 769.222  Millions
Co diagnostics Inc   0.02 $ 0.718  Millions$ 34.362  Millions
Fate Therapeutics Inc   0.02 $ 6.316  Millions$ 329.789  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.680  Millions$ 37.381  Millions
Vistagen Therapeutics Inc   0.02 $ 1.269  Millions$ 70.690  Millions
Anteris Technologies Global Corp   0.02 $ 1.851  Millions$ 108.593  Millions
Envoy Medical Inc   0.02 $ 0.234  Millions$ 14.115  Millions
Aim Immunotech Inc   0.02 $ 0.094  Millions$ 5.998  Millions
Alumis inc   0.02 $ 8.402  Millions$ 545.617  Millions
Rallybio Corporation  0.01 $ 0.858  Millions$ 58.849  Millions
Entrada Therapeutics Inc   0.01 $ 5.738  Millions$ 393.644  Millions
Crinetics Pharmaceuticals Inc   0.01 $ 18.069  Millions$ 1,253.296  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 2.526  Millions$ 176.533  Millions
Ataibeckley Inc   0.01 $ 3.488  Millions$ 246.656  Millions
Vyne Therapeutics Inc   0.01 $ 0.535  Millions$ 39.294  Millions
Medicinova Inc   0.01 $ 0.597  Millions$ 46.428  Millions
Prime Medicine Inc   0.01 $ 4.034  Millions$ 325.371  Millions
Vivosim Labs Inc   0.01 $ 0.131  Millions$ 10.925  Millions
Rafael Holdings Inc  0.01 $ 1.131  Millions$ 104.893  Millions
Silo Pharma Inc  0.01 $ 0.072  Millions$ 6.915  Millions
Upstream Bio Inc   0.01 $ 3.322  Millions$ 370.886  Millions
Absci Corp  0.01 $ 1.836  Millions$ 216.693  Millions
Cardiff Oncology Inc   0.01 $ 0.525  Millions$ 62.644  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.